SGAM
Smith Group Asset Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,790
| Closed | -$50K | – | 422 |
|
|
2019
Q2 | $50K | Hold |
1,790
| – | – | ﹤0.01% | 274 |
|
|
2019
Q1 | $59K | Sell |
1,790
-5,500
| -75% | -$181K | ﹤0.01% | 292 |
|
|
2018
Q4 | $212K | Sell |
7,290
-200
| -3% | -$5.82K | 0.01% | 239 |
|
|
2018
Q3 | $345K | Buy |
+7,490
| New | +$345K | 0.01% | 213 |
|
|
2017
Q3 | – | Sell |
-14,290
| Closed | -$369K | – | 462 |
|
|
2017
Q2 | $369K | Sell |
14,290
-100
| -0.7% | -$2.58K | 0.01% | 230 |
|
|
2017
Q1 | $276K | Sell |
14,390
-10
| -0.1% | -$192 | 0.01% | 233 |
|
|
2016
Q4 | $240K | Sell |
14,400
-100
| -0.7% | -$1.67K | 0.01% | 236 |
|
|
2016
Q3 | $298K | Hold |
14,500
| – | – | 0.01% | 218 |
|
|
2016
Q2 | $444K | Sell |
14,500
-400
| -3% | -$12.2K | 0.01% | 185 |
|
|
2016
Q1 | $558K | Sell |
14,900
-160
| -1% | -$5.99K | 0.02% | 168 |
|
|
2015
Q4 | $650K | Buy |
+15,060
| New | +$650K | 0.02% | 192 |
|
|
2015
Q2 | – | Sell |
-328
| Closed | -$12K | – | 421 |
|
|
2015
Q1 | $12K | Buy |
328
+127
| +63% | +$4.65K | ﹤0.01% | 379 |
|
|
2014
Q4 | $6K | Hold |
201
| – | – | ﹤0.01% | 389 |
|
|
2014
Q3 | $7K | Sell |
201
-492,177
| -100% | -$17.1M | ﹤0.01% | 356 |
|
|
2014
Q2 | $19.2M | Buy |
492,378
+492,200
| +276,517% | +$19.2M | 0.71% | 64 |
|
|
2014
Q1 | $6K | Sell |
178
-758,861
| -100% | -$25.6M | ﹤0.01% | 356 |
|
|
2013
Q4 | $15.9M | Hold |
759,039
| – | – | 0.6% | 72 |
|
|
2013
Q3 | $17.8M | Hold |
759,039
| – | – | 0.74% | 61 |
|
|
2013
Q2 | $20.4M | Buy |
+759,039
| New | +$20.4M | 0.88% | 44 |
|